Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17331541 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
Conditions: Cognitive Impairment;   Stroke
Interventions: Drug: choline alfoscerate;   Drug: placebo (for choline alphoscerate)

Indicates status has not been verified in more than two years